If you liked this article you might like

Loxo Oncology Aims for Genetic Mutation Cancer Drug Approval in 2018
'Mad Money' Lightning Round: Jim Cramer Focuses on Airline, Bank Stocks
Jim Cramer's 'Mad Money' Recap: Don't Miss This Rotation Back Into the Nasdaq
The Market Offers Some Opportunities but They're Disappearing Fast